Publications

Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3).
J Dermatolog Treat 2017 Jun 13;28(4):282-287. Epub 2016 Nov 13.
h Department of Medicine, Division of Dermatology , UCLA David Geffen School of Medicine , Los Angeles , CA , USA.






Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
N Engl J Med 2016 Jul 8;375(4):345-56. Epub 2016 Jun 8.
From the Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago (K.B.G.); Oregon Medical Research Center, Portland (A.B.); K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), and the Department of Medicine, Division of Dermatology, Dalhousie University, Halifax, NS (R.G.L.) - both in Canada; the Department of Dermatology, University of Münster, Münster (T.L.), and SCIderm Research Institute and Dermatologikum Hamburg, Hamburg (K.R.) - both in Germany; the Department of Dermatology, Jichi Medical University, Shimotsuke-shi, Japan (M.O.); Lilly Research Laboratories, Eli Lilly, Indianapolis (D.A., S.G.B., D.K.B., G.S.C., J.E., R.J.K., T.M.M., B.J.N., O.O.O., R.J.S., F.Z., L.M.); and the Department of Dermatology, Saint Louis University School of Medicine, St. Louis (C.L.L.).

Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis.
J Allergy Clin Immunol 2016 Jun 15;137(6):1882-1884.e6. Epub 2016 Mar 15.
Interdisciplinary Apheresis Centre, Reinbek, Germany; Hospital St. Adolf-Stift, Reinbek, Germany; Nephrology Centre Reinbek and Geesthacht, Reinbek, Germany.

Patient-relevant treatment goals in psoriasis.
Arch Dermatol Res 2016 Mar 19;308(2):69-78. Epub 2015 Dec 19.
German Center for Health Services Research in Dermatology (CVderm), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.

Exploration of SNP variants affecting hair colour prediction in Europeans.
Int J Legal Med 2015 Sep 11;129(5):963-75. Epub 2015 Jul 11.
Forensic Genetics Unit, Institute of Legal Medicine, University of Santiago de Compostela, A Coruña, Spain.



Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis.
J Dtsch Dermatol Ges 2015 Jul 15;13(7):674-90. Epub 2015 Jun 15.
Institute for Health Services Research in Dermatology and Nursing (IVPD), German Center for Health Sevices Research in Dermatology (CVderm), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.


A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
N Engl J Med 2015 Jul;373(2):136-44
From the Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago (K.B.G.); the Department of Dermatology, University of Utah School of Medicine, Salt Lake City (K.C.D.); Innovaderm Research, Montreal (R.B.); the Department of Dermatology, Ludwig-Maximilians-Universität München, Munich (J.C.P.), and the Dermatologikum Hamburg, Hamburg (K.R.) - both in Germany; and Janssen Research and Development, Spring House (Y.W., S.L., Y.-K.S., P.S., B.R.), and the Department of Dermatology, University of Pennsylvania, Philadelphia (B.R.) - both in Pennsylvania.


Topical long-term therapy of psoriasis with vitamin D₃ analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice.
J Dtsch Dermatol Ges 2014 Aug 17;12(8):667-82. Epub 2014 Jul 17.
CVderm - Centre of Excellence for Health Services Research in Dermatology; Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Secukinumab in plaque psoriasis--results of two phase 3 trials.
N Engl J Med 2014 Jul 9;371(4):326-38. Epub 2014 Jul 9.
From Dalhousie University, Halifax, NS (R.G.L.), Clinical Research (K.P.) and Probity Medical Research (K.P., L.S.), Waterloo, ON, and Stratica Medical and Probity Medical Research, Edmonton, AB (N.W.) - all in Canada; University of Alabama, Birmingham (B.E.E.); Mount Sinai Hospital, New York (M.L.); Dermatologikum Hamburg and Georg-August-Universität, Göttingen, Germany (K.R.); Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom (C.E.M.G.); Hospital de Sant Pau, Barcelona (L.P.); Jikei University School of Medicine, Tokyo (H.N.); Veracity Clinical Research, Woolloongabba, QLD, Australia (L.S.); Faculty of Medicine, Department of Dermatology, University of Iceland, Reykjavik (B.S.); Dermos, Guatemala City, Guatemala (E.R.); Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei (T.-F.T.); University of Texas Health Science Center and Center for Clinical Studies, Houston (S.T.); and Novartis Pharma, Basel, Switzerland (T.S., I.H., M.N., A.K., S.H., C.P.).


German psoriasis registry PsoBest: objectives, methodology and baseline data.
J Dtsch Dermatol Ges 2014 Jan;12(1):48-57
IVDP - Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

National and multinational guidelines in Europe: results from an online survey on awareness of different national and European psoriasis guidelines.
Arch Dermatol Res 2013 Sep 16;305(7):637-43. Epub 2013 Apr 16.
Division of Evidence-Based Medicine, Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin Berlin, Germany.


No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study.
Arch Dermatol Res 2012 Jul 11;304(5):353-61. Epub 2012 May 11.
Department of Dermatology, Venereology, and Allergology, Georg August University Göttingen, Robert-Koch-Strasse 40, 37075, Göttingen, Germany.









OF